• LAST PRICE
    8.7700
  • TODAY'S CHANGE (%)
    Trending Up0.2300 (2.6932%)
  • Bid / Lots
    8.3000/ 1
  • Ask / Lots
    9.1800/ 1
  • Open / Previous Close
    8.5400 / 8.5400
  • Day Range
    Low 8.5325
    High 9.1700
  • 52 Week Range
    Low 4.8400
    High 48.7500
  • Volume
    661,550
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 8.54
TimeVolumeCCCC
09:32 ET16018.54
09:34 ET5008.605
09:36 ET40898.62
09:38 ET101808.5566
09:39 ET4668.62
09:41 ET110678.65
09:43 ET112188.64
09:45 ET33028.74
09:52 ET3008.82
09:54 ET1008.84
09:56 ET4128.88
09:57 ET21978.9604
09:59 ET37358.94
10:01 ET57478.85
10:03 ET13518.89
10:06 ET42578.85
10:08 ET304908.79
10:10 ET80008.845
10:12 ET8008.91
10:14 ET13498.88
10:15 ET248948.84
10:17 ET16148.855
10:19 ET157588.85
10:21 ET131938.9
10:24 ET104789.02
10:26 ET95009.01
10:28 ET119128.92
10:30 ET228898.965
10:32 ET160519.02
10:33 ET95888.95
10:35 ET29588.97
10:37 ET11298.96
10:39 ET2008.965
10:42 ET24968.99
10:44 ET77959.065
10:46 ET23379.11
10:48 ET10309.13
10:50 ET55719.1
10:51 ET56499.14
10:55 ET22399.1
10:57 ET1009.1
11:00 ET12209.08
11:02 ET16519.08
11:04 ET8159.06
11:08 ET1009.06
11:09 ET12349.08
11:11 ET14569.09
11:13 ET5359.08
11:15 ET28009.085
11:18 ET12009.095
11:20 ET34039.1
11:22 ET42049.155
11:24 ET24199.07
11:26 ET13159.08
11:27 ET1009.08
11:29 ET5439.065
12:07 ET7019.03
12:09 ET10149.02
12:12 ET2009.04
12:14 ET7279.06
12:16 ET10009.03
12:20 ET11549.03
12:21 ET12179
12:25 ET2009.04
12:27 ET11599.06
12:30 ET17789.04
12:32 ET14269.06
12:34 ET1009.05
12:36 ET3779.08
12:38 ET6009.11
12:39 ET2009.12
12:41 ET19929.131
12:43 ET4839.13
12:48 ET4009.14
12:52 ET1009.14
12:54 ET10369.13
12:56 ET6409.125
12:57 ET3449.13
12:59 ET11579.115
01:01 ET1109.12
01:03 ET23549.12
01:08 ET11009.11
01:10 ET11199.1
01:12 ET4029.11
01:15 ET10669.08
01:17 ET6009.06
01:24 ET20189.03
01:26 ET1008.99
01:28 ET3009
01:30 ET3009.0468
01:35 ET21758.985
01:37 ET9069
01:39 ET1009
01:46 ET1009.01
01:48 ET14868.96
01:53 ET9388.96
02:00 ET4108.95
02:02 ET4968.96
02:04 ET2508.97
02:08 ET3009
02:11 ET5009
02:13 ET17439
02:15 ET3009
02:18 ET2009
02:20 ET8198.98
02:22 ET2009
02:24 ET9129
02:26 ET1008.99
02:29 ET10258.985
02:31 ET3129
02:33 ET14538.95
02:36 ET6008.97
02:38 ET6178.965
02:40 ET5008.98
02:44 ET6098.97
02:45 ET5008.97
02:47 ET3308.95
02:49 ET17988.96
02:54 ET13088.94
02:56 ET6088.94
02:58 ET9008.9
03:00 ET12918.88
03:02 ET2008.88
03:03 ET8278.93
03:05 ET21528.92
03:09 ET10108.93
03:12 ET8819
03:14 ET14418.93
03:16 ET8488.93
03:18 ET13598.93
03:20 ET8008.89
03:21 ET8638.88
03:23 ET4438.9
03:25 ET2088.905
03:27 ET1008.905
03:30 ET32828.9
03:32 ET7938.9
03:34 ET9148.8425
03:36 ET11008.86
03:38 ET12228.87
03:39 ET23008.855
03:41 ET19698.8
03:43 ET14208.825
03:45 ET9458.82
03:48 ET19958.84
03:50 ET14088.855
03:52 ET19958.815
03:54 ET67318.795
03:56 ET12078.805
03:57 ET18138.785
03:59 ET62588.77
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCCCC
C4 Therapeutics Inc
419.2M
-4.3x
---
United StatesTARS
Tarsus Pharmaceuticals Inc
432.7M
-6.4x
---
United StatesALBO
Albireo Pharma Inc
355.2M
-10.2x
---
United StatesPTGX
Protagonist Therapeutics Inc
402.5M
-3.1x
---
United StatesADCT
ADC Therapeutics SA
358.4M
-2.0x
---
United StatesWVE
WAVE Life Sciences Ltd
325.6M
-1.8x
---
As of 2022-10-01

Company Information

C4 Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on harnessing the body’s natural regulation of protein levels to develop therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. The Company provides technology platform, Target ORiented ProtEin Degrader Optimizer (TORPEDO), to synthesize a new class of small molecule protein degraders that are designed to destroy disease-causing proteins, including targets previously considered to be undruggable. The Company’s lead product candidates, CFT7455, is an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma (MM), peripheral T-cell lymphoma (PTCL), and mantle cell lymphoma (MCL). The Company is also developing CFT8634, an orally bioavailable degrader of a protein target called bromodomain containing 9 (BRD9), for synovial sarcoma and SMARCB1-deleted solid tumors.

Contact Information

Headquarters
490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
Phone
617-231-0700
Fax
302-655-5049

Executives

Executive Chairman of the Board, Co-Founder
Marc Cohen
President, Chief Executive Officer, Director
Andrew Hirsch
Chief Financial Officer, Treasurer
Lauren White
Chief People Officer
Kelly Schick
Chief Scientific Officer
Stewart Fisher

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$419.2M
Revenue (TTM)
$50.1M
Shares Outstanding
48.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.04
Book Value
$8.00
P/E Ratio
-4.3x
Price/Sales (TTM)
8.4
Price/Cash Flow (TTM)
---
Operating Margin
-196.26%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.